Comparison of Vision Transformers and Convolutional Neural Networks in Medical Image Analysis: A Systematic Review.

Autor: Takahashi S; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan., Sakaguchi Y; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Neurosurgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Kouno N; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan.; Department of Surgery, Graduate School of Medicine, Kyoto University, Yoshida-konoe-cho, Sakyo-ku, Kyoto, 606-8303, Japan., Takasawa K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan., Ishizu K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Akagi Y; Department of Biomedical Informatics, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo Bunkyo-ku, Tokyo, 113-8655, Japan., Aoyama R; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Obstetrics and Gynecology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan., Teraya N; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Department of Obstetrics and Gynecology, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan., Bolatkan A; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan., Shinkai N; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan., Machino H; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan., Kobayashi K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan., Asada K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan., Komatsu M; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan., Kaneko S; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan., Sugiyama M; RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Hamamoto R; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. rhamamot@ncc.go.jp.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, 1-4-1 Nihonbashi, Chuo-ku, Tokyo, 103-0027, Japan. rhamamot@ncc.go.jp.

Publikováno v: Journal of medical systems [J Med Syst] 2024 Sep 12; Vol. 48 (1), pp. 84. Date of Electronic Publication: 2024 Sep 12.

Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations.

Autor: Kaneko S; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. sykaneko@ncc.go.jp.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan. sykaneko@ncc.go.jp., Takasawa K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Asada K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Shiraishi K; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Ikawa N; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan., Machino H; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Shinkai N; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Matsuda M; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Masuda M; Department of Proteomics, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Adachi S; Department of Proteomics, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Takahashi S; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Kobayashi K; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Kouno N; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Bolatkan A; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Komatsu M; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan., Yamada M; Endoscopy Division, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Miyake M; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Watanabe H; Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Tateishi A; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Mizuno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan.; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan.; Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Okubo Y; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Mukai M; Division of Medical Informatics, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Yoshida T; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Yoshida Y; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Horinouchi H; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Watanabe SI; Department of Thoracic Surgery, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Yatabe Y; Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, 104-0045, Japan., Saloura V; Center for Cancer Research, National Cancer Institute, Bethesda, MD, 20892, USA., Kohno T; Division of Genome Biology, National Cancer Center Research Institute, Tokyo, 104-0045, Japan., Hamamoto R; Division of Medical AI Research and Development, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-Ku, Tokyo, 104-0045, Japan. rhamamot@ncc.go.jp.; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo, 103-0027, Japan. rhamamot@ncc.go.jp.

Publikováno v: Molecular cancer [Mol Cancer] 2024 Jun 11; Vol. 23 (1), pp. 126. Date of Electronic Publication: 2024 Jun 11.

Virucidal efficacy of hypochlorous acid water for aqueous phase and atomization against SARS-CoV-2.

Autor: Kubo M; Department of Microbiology, Kitasato University School of Allied Health Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan; Department of Environmental Microbiology, Kitasato University Graduate School of Medical Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan; Research Facility of Regenerative Medicine and Cell Design, Kitasato University School of Allied Health Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan E-mail: kuboma@kitasato-u.ac.jp., Eda R; Department of Microbiology, Kitasato University School of Allied Health Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan; Department of Environmental Microbiology, Kitasato University Graduate School of Medical Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan; Research Facility of Regenerative Medicine and Cell Design, Kitasato University School of Allied Health Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan., Maehana S; Department of Microbiology, Kitasato University School of Allied Health Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan; Department of Environmental Microbiology, Kitasato University Graduate School of Medical Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan; Research Facility of Regenerative Medicine and Cell Design, Kitasato University School of Allied Health Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan., Fuketa H; NIPRO Corporation, Pharmaceutical Research Laboratories, 7-2 Minamisakae-cho Kasukabe, Saitama 344-0057, Japan., Shinkai N; NIPRO Corporation, Pharmaceutical Research Laboratories, 7-2 Minamisakae-cho Kasukabe, Saitama 344-0057, Japan., Kawamura N; NIPRO Corporation, Pharmaceutical Research Laboratories, 7-2 Minamisakae-cho Kasukabe, Saitama 344-0057, Japan., Kitasato H; Department of Microbiology, Kitasato University School of Allied Health Sciences, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0373, Japan., Hanaki H; Infection Control Research Center, The Omura Satoshi Memorial Institution, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8641, Japan.

Publikováno v: Journal of water and health [J Water Health] 2024 Mar; Vol. 22 (3), pp. 601-611. Date of Electronic Publication: 2024 Feb 14.

Efficacy of cognitive behavioral therapy using self-check sheet for patients with nocturia in real-world clinical practice.

Autor: Kyoda Y; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.; Yakumo General Hospital, Yakumo, Japan.; Hokkaido Prefectural Haboro Hospital, Haboro, Japan.; Rumoi Municipal Hospital, Rumoi, Japan., Ichihara K; Sapporo Central Hospital, Sapporo, Japan., Muranaka I; Hokkaido Social Work Association Obihiro Hospital, Obihiro, Japan., Sakai Y; Takikawa Municipal Hospital, Takikawa, Japan., Nakamura M; Muroran City General Hospital, Muroran, Japan., Shinkai N; Saiseikai Otaru Hospital, Otaru, Japan., Kozen N; JCHO Hokkaido Medical Center, Sapporo, Japan., Yorozuya W; Kushiro Red Cross Hospital, Kushiro, Japan., Morooka D; Asahikawa Red Cross Hospital, Asahikawa, Japan., Maruo K; Hokkaido Medical Center, Sapporo, Japan., Tachikawa K; Hakodate Goryoukaku Hospital, Hakodate, Japan., Shibamori K; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.; Kuriyama Red Cross Hospital, Kuriyama, Japan.; Hokkaido Social Work Association Toya Hospital, Toyako, Japan.; JCHO Noboribetsu Medical Center, Noboribetsu, Japan., Nofuji S; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.; Kuriyama Red Cross Hospital, Kuriyama, Japan.; Hokkaido Social Work Association Toya Hospital, Toyako, Japan.; JCHO Noboribetsu Medical Center, Noboribetsu, Japan., Fujino K; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.; Kuriyama Red Cross Hospital, Kuriyama, Japan.; Hokkaido Social Work Association Toya Hospital, Toyako, Japan.; JCHO Noboribetsu Medical Center, Noboribetsu, Japan., Kato S; Oji General Hospital, Tomakomai, Japan., Yoshida T; NTT-East Sapporo Hospital, Sapporo, Japan., Shindo T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan., Maehana T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan., Hashimoto K; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan., Kobayashi K; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.; Nemuro City Hospital, Nemuro, Japan., Tanaka T; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan., Masumori N; Department of Urology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Publikováno v: Lower urinary tract symptoms [Low Urin Tract Symptoms] 2023 Nov; Vol. 15 (6), pp. 225-230. Date of Electronic Publication: 2023 Aug 23.

Clinical factors related to long-term administration of sorafenib in patients with hepatocellular carcinoma

Autor: Nojiri S, Kusakabe A, Fujiwara K, Shinkai N, Matsuura K, Iio E, Miyaki T, Nomura T, Sobue S, Sano H, Hasegawa I, Ohno T, Takahashi Y, Orito E, Joh T

Publikováno v: Cancer Management and Research, Vol 2012, Iss default, Pp 423-429 (2012)

Shunsuke Nojiri,1 Atsunori Kusakabe,1 Kei Fujiwara,1 Noboru Shinkai,1 Kentaro Matsuura,1 Etsuko Iio,1 Tomokatsu Miyaki,1 Tomoyuki Nomura,2 Satoshi Sobue,3 Hitoshi Sano,4 Izumi Hasegawa,5 Tomoyoshi Ohno,5 Yoshitsugu Takahashi,6 Etsuro Orito,7 Takashi

Externí odkaz: https://doaj.org/article/cc977696393c4a20a039f8eb86fea3ff